2982 Federal Register / Vol. 63, No. 12 / Tuesday, January 20, 1998 / Notices

§ 225.28(b)(4)(ii) of the Board’s

Regulation Y.

Board of Governors of the Federal Reserve

System, January 13, 1998.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 98–1173 Filed 1–16–98; 8:45 am]

BILLING CODE 6210–01–F

FEDERAL RESERVE SYSTEM

Notice of Proposals To Engage in

Permissible Nonbanking Activities or

To Acquire Companies That Are

Engaged in Permissible Nonbanking

Activities

The companies listed in this notice

have given notice under section 4 of the

Bank Holding Company Act (12 U.S.C.

1843) (BHC Act) and Regulation Y, (12

CFR Part 225) to engage de novo, or to

acquire or control voting securities or

assets of a company that engages either

directly or through a subsidiary or other

company, in a nonbanking activity that

is listed in § 225.28 of Regulation Y (12

CFR 225.28) or that the Board has

determined by Order to be closely

related to banking and permissible for

bank holding companies. Unless

otherwise noted, these activities will be

conducted throughout the United States.

Each notice is available for inspection

at the Federal Reserve Bank indicated.

The notice also will be available for

inspection at the offices of the Board of

Governors. Interested persons may

express their views in writing on the

question whether the proposal complies

with the standards of section 4 of the

BHC Act.

Unless otherwise noted, comments

regarding the applications must be

received at the Reserve Bank indicated

or the offices of the Board of Governors

not later than February 3, 1998.

A. Federal Reserve Bank of Cleveland

(Jeffery Hirsch, Banking Supervisor)

1455 East Sixth Street, Cleveland, Ohio

44101-2566:

1. F.N.B. Corporation, Hermitage,

Pennsylvania, and F.N.B. Corporation to

acquire shares of Pennsylvania Sun Life

Insurance Company, Phoenix, Arizona,

and thereby engage in providing credit

life and disability insurance exclusively

to customers of Sun Bank, Sun Bancorp,

Inc.’s bank subsidiary, pursuant to §

225.25(b)(8)(i) of the Board’s Regulation

Y.

B. Federal Reserve Bank of St. Louis

(Randall C. Sumner, Vice President) 411

Locust Street, St. Louis, Missouri 63102-

2034:

1. First Commercial Corporation

(‘‘FCC’’), Little Rock, Arkansas; to

acquire First Commercial Investments,

Inc. (‘‘Company’’), Little Rock,

Arkansas, and thereby engage in

underwriting and dealing in, to a

limited extent, securities (See Citicorp,

73 Fed. Res. Bull. 473 (1987)); providing

investment and financial advisory

services, pursuant to § 225.28(b)(6) of

the Board’s Regulation Y; providing

advice and acting as arranger in

connection with merger, acquisitions,

divestiture and financial transactions,

including public and private financings,

loan syndications, interest rate and

currency swaps, interest rate caps and

similar transactions and/or furnishing

evaluation and fairness opinions in

connection with merger, acquisition,

and similar transactions, pursuant to §§

225.28(b)(6) and (b)(7) of the Board’s

Regulation Y; providing securities

brokerage services on either a standalone or full-service basis, pursuant to §

225.28(b)(7)(i) of the Board’s Regulation

Y; buying and selling all types of

securities on the order of investors as

riskless principal, pursuant to §

225.28(b)(7)(ii) of the Board’s Regulation

Y; acting as agent for issuers and

holders in the private placement of

securities, pursuant to § 225.28(b)(7)(iii)

of the Board’s Regulation Y;

underwriting and dealing in bank

eligible securities, pursuant to §

225.28(b)(8) of the Board’s Regulation Y;

and providing management consulting

and counseling services, pursuant to §

225.28(b)(9) of the Board’s Regulation Y.

Board of Governors of the Federal Reserve

System, January 14, 1998.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 98–1268 Filed 1–16–98; 8:45 am]

BILLING CODE 6210–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[INFO–98–08]

Proposed Data Collections Submitted

for Public Comment and

Recommendations

In compliance with the requirement

of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995 for

opportunity for public comment on

proposed data collection projects, the

Centers for Disease Control and

Prevention (CDC) and the Agency for

Toxic Substances and Disease Registry

(ATSDR) will publish periodic

summaries of proposed projects. To

request more information on the

proposed projects or to obtain a copy of

the data collection plans and

instruments, call the CDC/ATSDR

Reports Clearance Officer on (404) 639–

7090.

Comments are invited on: (a) Whether

the proposed collection of information

is necessary for the proper performance

of the functions of the agency, including

whether the information shall have

practical utility; (b) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information; (c)

ways to enhance the quality, utility, and

clarity of the information to be

collected; and (d) ways to minimize the

burden of the collection of information

on respondents, including through the

use of automated collection techniques

for other forms of information

technology. Send comments to Wilma

Johnson, CDC/ATSDR Reports

Clearance Officer, 1600 Clifton Road,

MS–D24, Atlanta, GA 30333. Written

comments should be received within 60

days of this notice.

Proposed Projects

1. Model Performance Evaluation

Program for Retroviral and AIDSRelated Testing—(0920–0274)—

Extension—Public Health Practice

Program Office (PHPPO). The CDC

Model Performance Evaluation Program

(MPEP) currently assesses the

performance of laboratories that test for

human immunodeficiency virus type 1

(HIV–1) antibody, human Tlymphotropic virus types I and II

(HTLV–I/II) antibody, perform CD4 Tcell testing or T-lymphocyte

immunophenotyping (TLI) by flow

cytometry or alternate methods, perform

HIV–1 ribonucleic acid (RNA)

determinations (viral load), and test for

HIV–1 p24 antigen through the use of

mailed sample panels. The CDC MPEP

is proposing to use annual data

collection documents to gain updated

information on the characteristics of

testing laboratories and their testing

practices. Two data collection

instruments, or survey questionnaires,

will be used. The first data collection

instrument will be concerned with

laboratories that perform HIV–1

antibody (Ab) testing, HTLV–I/II Ab

testing, HIV–1 viral RNA

determinations, and HIV–1 p24 antigen

(Ag) testing. Laboratories enrolled in the

MPEP will be mailed a survey

questionnaire and be asked to complete

the sections pertinent to their

laboratory’s testing. The survey

instrument will collect demographic

information related to laboratory type,

primary purpose for testing, types of

specimens tested, minimum education

requirements of testing personnel,

laboratory director, and laboratory
Federal Register / Vol. 63, No. 12 / Tuesday, January 20, 1998 / Notices 2983

supervisor, and training required of

testing personnel. The demographic

section will be followed by more

specific sections related directly to HIV–

1 Ab testing, HTLV–I/II Ab testing, HIV–

1 RNA, and HIV–1 p24 Ag testing.

Included in the latter sections will be

questions related to the types of tests

performed, the algorithm of testing, how

test results are interpreted, how results

are reported, how specimens may be

rejected for testing, if some testing is

referred to other laboratories, and what

quality control and quality assurance

procedures are conducted by the

laboratory. Similarly, the TLI survey

questionnaire will also collect

demographic information about each

laboratory, as well as, the type(s) of flow

cytometer used, educational and

training requirements of testing

personnel, the types of monoclonal

antibodies used in testing, how

specimens are received, prepared, and

stored, how test results are recorded and

reported to the test requestor, and what

quality control and quality assurance

procedures are practiced. Information

collected through the use of these

instruments will enable CDC to

determine if laboratories are conforming

to published recommendations and

guidelines, whether education and

training requirements of testing

personnel are conforming to current

legislative requirements, and whether

problems in testing can be identified

through the collection of information.

Information collected through the

survey instruments will then be

compared statistically with the

performance evaluation results reported

by the enrolled laboratories to

determine if characteristics of

laboratories that perform well can be

distinguished from laboratories not

performing as well. Upon enrolling in

the MPEP, participants are assigned an

MPEP number used to report testing

results and survey questionnaire

responses allowing the individual

responses of each laboratory participant

to be treated in confidence. When

participants respond to the surveys by

sending CDC completed questionnaires,

the collected information is developed

into aggregate reports. A copy of the

completed report is provided to each

participating laboratory. Other than

their time, there will be no cost to the

respondents.

Respondents Number of respondents

No. of respondents/responseAverage burden/response

(in hrs)

Total burden

(in hrs)

MPEP Enrollment Form .................................................................................... 100 1 0.1 10

Retroviral Survey .............................................................................................. 1,000 1 0.5 500

TLI Survey ........................................................................................................ 350 1 0.5 175

Total ........................................................................................................... 685

2. Prostate and Colorectal Cancer

Screening in the Managed Care

Environment—New—National Center

for Chronic Disease Prevention and

Health Promotion (NCCDPHP). Prostate

and colorectal cancer are among the

leading causes of cancer deaths in the

U.S. Prostate cancer screening has

increased rapidly during the past few

years; however, little is known about

actual rates of screening, or the

proportion of men screened who present

with symptoms or who are at high risk

for prostate cancer. Evidence suggests

that colorectal cancer screening can save

lives and efforts are under way to

increase participation in screening.

However, little information is available

to monitor screening rates. It is also

unknown how well self-reported

prostate and colorectal cancer screening

rates, which are often used in

population surveys, compare to actual

screening rates. Therefore, the Centers

for Disease Control and Prevention

(CDC), National Center for Chronic

Disease Prevention and Health

Promotion, Division of Cancer

Prevention and Control, intends to

conduct a survey of prostate and

colorectal cancer screening test

utilization. As an increasing number of

people are served by managed care

organizations where they may receive

cancer screening tests, the proposed

study population are members of

managed care organizations.

A sample of members (men aged 40

years and older and women 50 years

and older) of 3 managed care

organizations will be interviewed over

the telephone, and the medical charts of

the participants will be abstracted. The

information collected will include

demographic information, prostate and

colorectal cancer screening tests

received within the past 5 years, and the

reasons and outcomes of the tests. The

total cost estimate is: $400,000.

Respondents No. of respondents

No. of responses/respondent

Average burden of response (in

hrs)

Total burden

(in hrs)

Members of Prepaid Health Plans ................................................................... 2200 1 0.25 550

3. Substance Specific Applied

Research Program (AMHPS) [King/Drew

Lead Study in-Person Interview, Lead

and Hypertension Screening

Questionnaire/Risk Factor

Questionnaire]—(0923–0015)—

EXTENSION—The Agency for Toxic

Substances and Disease Registry

(ATSDR) is mandated pursuant to the

1980 Comprehensive Environmental

Response Compensation and Liability

Act (CERCLA), and its 1986

Amendments, The Superfund

Amendments and Reauthorization Act

(SARA), to prevent or mitigate adverse

human health effects and diminished

quality of life resulting from the

exposure to hazardous substances into

the environment. Disadvantaged

minorities in large urban areas have

higher than national blood lead levels.

Some of these groups also suffer from

disproportionately high rates of

hypertension. Previous data shows a

relationship between higher blood lead

levels and higher blood pressure, even

at the lowest lead exposure. To facilitate

this effort, this study examines the

relationship between lead exposure

history in inner city minorities and

blood pressure, using a group at special

risk for elevated blood pressure,

pregnant women. Elevated blood lead
2984 Federal Register / Vol. 63, No. 12 / Tuesday, January 20, 1998 / Notices

and elevated blood pressure are two

problems that disproportionately affect

minority groups. Establishing a link

between blood pressure and lead

exposure, especially utilizing two new

biomarkers of lead exposure, bone lead

and serum lead, can provide a new tool

for dealing with elevated blood pressure

nationwide.

This request is for a 3-year extension.

Two previously approved

questionnaires will continue to be used

to collect socioeconomic data, and data

pertaining to risk factors for elevated

blood pressure and lead exposure. A

new questionnaire assessing social

stress (Scale of Chronic Social Role

Stressors) and a 16 item, four response

choice scale will be added to better

control for social stress factors affecting

blood pressure. There is no cost to

respondents.

Type of respondent

No. of respondents per

year

No. of responses/respondentAvg. burden per

response (in

hrs)

Total burden

(in hrs)

Screening Questionnaire ................................................................................ 880 1 .5 440

Social Role Stressors ..................................................................................... 880 1 .08 70

Risk Questionnaire ......................................................................................... 330 2 .75 495

Total ......................................................................................................... ........................ ........................ .......................... 1005

Dated: January 13, 1998.

Wilma G. Johnson,

Acting Associate Director for Policy Planning

and Evaluation, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 98–1206 Filed 1–16–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

Proposed Information Collection

Activity; Comment Request

Proposed Projects

Title: Community-Based Family

Resource and Support Grants.

OMB No.: 0970–0155.

Description: Application information

is required when a State wishes to

receive a Community-Based Family

Resource and Support (CBFRS) grant

award. This Program Instruction

contains information collection

requirements found in Pub. L. 104–235

at Sections 202(1)(A); 202(b)(1)(B); 205;

and 207. The information being

collected is required by statute to be

submitted pursuant to receiving a grant

award. The information submitted will

be used by the agency to ensure

compliance with the statute, complete

the calculation of the grant award

entitlement, provide training and

technical assistance to the grantee, and

evaluate State efforts in the prevention

of child abuse and neglect.

Respondents: State, Local or Tribal

Government.

ANNUAL BURDEN ESTIMATES

Instrument Number of

respondents

Number of

responses per

respondent

Average

burden hours

per response

Total burden

hours

Application ........................................................................................................ 57 1 40 2,280

Annual Report ................................................................................................... 57 1 40 1,368

Estimated Total Annual Burden

Hours: 3,648.

In compliance with the requirements

of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Administration for Children and

Families is soliciting public comment

on the specific aspects of the

information collection described above.

Copies of the proposed collection of

information can be obtained and

comments may be forwarded by writing

to the Administration for Children and

Families, Office of Information Services,

Division of Information Resource

Management Services, 370 L’Enfant

Promenade, SW., Washington, DC

20447, Attn: ACF Reports Clearance

Officer. All requests should be

identified by the title of the information

collection.

The Department specifically requests

comments on: (a) Whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information shall have

practical utility; (b) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information; (c)

the quality, utility, and clarity of the

information to be collected; and (d)

ways to minimize the burden of the

collection of information on

respondents, including through the use

of automated collection techniques or

other forms of information technology.

Consideration will be given to

comments and suggestions submitted

within 60 days of this publication.

Dated: January 13, 1998.

Bob Sargis,

Acting Reports Clearance Officer.

[FR Doc. 98–1183 Filed 1–16–98; 8:45 am]

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

Submission for OMB Review;

Comment Request

Title: Emergency TANF Data Report

(ACF–198).

OMB No.: 0970–0164.

Description: This information is being

collected to meet the statutory

requirements of section 411 of the

Social Security Act and section 116 of